- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cell, 180.2020, Nr. 3, S. 471-489.e22, doi:10.1016/j.cell.2020.01.010
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2020
- Creator
-
Schommers, Philipp
Grüll, Henning
Abernathy, Morgan E.
Tran, My-Kim
Dingens, Adam S.
Gristick, Harry B.
Barnes, Christopher O.
Schoofs, Till
Schlotz, Maike
Vanshylla, Kanika
Kreer, Christoph
Weiland, Daniela
Holtick, Udo
Scheid, Christof
Valter, Markus
Gils, Marit J. van
Sanders, Rogier W.
Vehreschild, Jörg Janne
Cornely, Oliver Andreas
Lehmann, Clara
Fätkenheuer, Gerd
Seaman, Michael S.
Bloom, Jesse D.
Bjorkman, Pamela J.
Klein, Florian
- URN
-
urn:nbn:de:hebis:30:3-530735
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schommers, Philipp
- Grüll, Henning
- Abernathy, Morgan E.
- Tran, My-Kim
- Dingens, Adam S.
- Gristick, Harry B.
- Barnes, Christopher O.
- Schoofs, Till
- Schlotz, Maike
- Vanshylla, Kanika
- Kreer, Christoph
- Weiland, Daniela
- Holtick, Udo
- Scheid, Christof
- Valter, Markus
- Gils, Marit J. van
- Sanders, Rogier W.
- Vehreschild, Jörg Janne
- Cornely, Oliver Andreas
- Lehmann, Clara
- Fätkenheuer, Gerd
- Seaman, Michael S.
- Bloom, Jesse D.
- Bjorkman, Pamela J.
- Klein, Florian
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2020
Other Objects (12)
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Antibody-induced restriction of viral gene expression in measles encephalitis in rats
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Antibody-induced restriction of viral gene expression in measles encephalitis in rats
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
Identification and characterization of new broadly neutralizing and potent HIV-1-antibodies by Env-specific B cell sorting
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
Antibody-induced restriction of viral gene expression in measles encephalitis in rats
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis